Key players of Exoskeleton Market are shaping the market size towards long-term market growth through 2025
The ongoing manifold activities of building and repair in the infrastructure, aerospace, and shipping industries are disrupting the mobility of exoskeleton market growth over the forecast period. The key market driver of Exoskeleton Market value is attributed to the large base of consumers is rapidly emerging across key end users- Healthcare, Military, and Industrial.
The increased demand for efficiency and improved patient outcome in the healthcare sector, followed by precision and robust performance in the military sector are concurrently met by the leading OEMs of Exoskeleton Market.
B-Temia, a key player of market, owns a patented technology called dermoskeleton that restores, maintains or enhances the mobility of users, both in healthcare and military field.
Wearable robot exoskeleton is among the emerging exoskeleton market trend largely penetrating the market growth with surging innovation and development of medical exoskeleton products by key OEMs.
In July 2019, Ekso Bionics Holdings, Inc. announced the expansion of its medical exoskeleton portfolio with an upper extremity rehabilitation device called EksoUE. The wearable upper body exoskeleton provides a broad range of motion, upper extremity impairment and increased endurance for rehabilitation sessions.
Prominent players contributing towards the exoskeleton market growth include Bionik Laboratories, B-Temia, Cyberdyne, Ekso Bionics, Focal Meditech, DIH Technologies, Lockheed Martin, Ottobock, Rewalk Robotics, Meditouch, Atoun, Daiya Industry Co., Honda Motor, Mitsubishi Heavy Industries, Parker Hannifin, Rex Bionics, Gobio Robot, Myomo, Wandercraft, P&S Mechanics, and Hyundai Motor.
Medical Exoskeleton Market Highlights
In May 2019, Ekso Bionics Holdings, Inc. announced groundbreaking clinical study for three EksoGT exoskeletons in Singapore by NUHS. EksoGT is the FDA/ CE cleared exoskeleton to work with patients impacted by all neurological conditions and lower limb weakness.
In June 2018, Wistron Corporation and B-Temia Inc. announced joint venture agreement ot commercialize Keeogo in several countries in Asia such as China, Japan and Australia. Keeogo is a novel type of lightweight exoskeleton lower limb provides a true human-machine interface, in particular for aging population.
About Ekso Bionics
Ekso Bionics established in 2005 is a pioneer player of exoskeleton market, a leader in amplifying human potential by enhancing strength, endurance, and mobility across medical and industrial applications. The R & D expenses for the quarter ended June 30, 2019 was $1.5 million and total second quarter 2019 revenues summed up to $3.3 million.
About Wistron Corporation
Wistron Corporation Ld. is ODM delivering information & communication technology product services across military, healthcare and industrial sectors, with headquarters in Taiwan and located across Asia, Americas and Europe.
Military Exoskeleton Market Highlights
In late 2018, B-Temia Inc. signed $6.9M USD U.S. agreement with Army Natick Soldier Research, Development and Engineering Center (NSRDEC) with its partner Lockheed Martin for the optimization of the ONYX exoskeleton, for field trials with military operators.
Another military exoskeleton product largely penetrating the exoskeleton market HULC manufactured by Lockheed Martin and Ekso Bionics joint venture. US army trials for HULC (human universal load carrier)is showcasing ease in the mobility of war fighters aiding in carrying 200lbs without strain on the wearer.
Military Exoskeleton Market growth is also marked by Lockheed Martin, a pioneer in exoskeleton suit and owns lower-body ONYX brand, which won a popular science award in 2018. According to the Soldier Center’s $6.9m budget, around $680,000 has been put aside for Lockheed Martin’s Onyx.
B-Temia is a Canadian robotics technology company founded in 2010 and is known for its cutting edge exoskeleton products for medical, industrial, military fields and other emerging sectors. B-Temia operates through two wholly-owned subsidiaries, B-Temia Inc. and B-Temia USA Inc and is known for its huge contribution towards growing market of exoskeleton and human augmentation systems.
About Lockheed Martin
Lockheed Martin, headquartered in Bethesda, Maryland, is among the prominent player of market and is engaged in the research, development, integration and sustainment of advanced Exoskeleton products and services.